INTRODUCTION:
Patients undergoing open cranial vault remodeling for craniosynostosis frequently experience high blood loss and require transfusion. Although multiple strategies have been proposed, little consensus exists regarding best practices. [1] [2] [3] [4] We have developed a novel blood conservation protocol.
METHODS:
Forty-one consecutive patients undergoing open cranial vault remodeling were retrospectively reviewed. Early in the series, individual anesthesiologist preference dictated aminocaproic acid (ACA) use, and no patients received erythropoietin (EPO). After protocol initiation, all patients were evaluated for EPO and all patients received intraoperative ACA. Transfusion guidelines were defined. Cell Saver device was used when possible. Comparisons were made between the new protocol "ACA+EPO Group" (received ACA, received EPO), the pre-protocol "ACA Only Group" (received ACA, did not receive EPO), and the pre-protocol "No ACA Group" (did not receive ACA, did not receive EPO). Tukey's HSD Test was used to compare groups on patient characteristics, estimated blood loss (EBL), and allogeneic packed red blood cell transfusion volume.
RESULTS:
Age, weight, and surgery time were similar across all groups (p>0.05). Hemoglobin and hematocrit increased after EPO administration from 11.3/32.8 to 15.1/47.3 (p<0.05).
The ACA+EPO Group (n=9) had mean EBL of 11.7cc/kg (sd=10.4) and mean transfusion volume of 1.0cc/kg (sd=3.0). This group includes 8 patients (89%) not requiring transfusion intraoperatively and 6 patients (67%) discharged from the hospital transfusion-free. One patient (11%) received autologous transfusion from Cell Saver. The ACA Only Group (n=11) had mean EBL of 16.7cc/kg (sd=12.6) and mean transfusion volume of 17.1cc/kg (sd=23.1). This group includes 4 patients (36%) not requiring transfusion intraoperatively and 3 patients (27%) discharged from the hospital transfusion-free. Two patients (18%) received autologous transfusion from Cell Saver. The No ACA Group (n=21) had mean EBL of 44.7cc/kg (sd=24.1) and mean transfusion volume of 44.0cc/kg (sd=39.3). All patients required transfusion intraoperatively. Three patients (14%) received autologous transfusion from Cell Saver. The ACA+EPO Group had significantly lower EBL and transfusion volume compared to the No ACA Group (p<0.05). The ACA+EPO Group required less transfusion volume than the ACA only group, however this difference was not statistically significant (p>0.05).
CONCLUSION:
Our protocol emphasizing EPO and ACA decreases EBL and transfusion volume compared to a group not receiving ACA. Further data will be required to elucidate the efficacy of this protocol in reducing transfusion volume compared to an ACA only protocol.
INTRODUCTION:
Pediatric craniofacial procedures are complex and require intensive preoperative, intraoperative, and postoperative care. Transfusions are often required due to both the invasive nature of the procedure as well as the inherently lower blood volume in pediatric patients. We report here our experience with a multidisciplinary Blood Management Team in complex craniofacial surgery.
OBJECTIVES:
To determine if a Pediatric Blood Management (PBM) program with multimodal approach can reduce transfusion requirements in pediatric patients undergoing craniofacial surgery.
METHODS:
A collaborative protocol was developed by the PBM team, plastic surgery and anesthesia clinicians in 2016, which involved the pre-operative optimization of hemoglobin levels, the intraoperative use of tranexamic acid and CellSaver™ technology, as well as blood sparing operative techniques. Additionally, patients were preoperatively screened for altered coagulation including hypofibrinogenemia and von Willebrand's disease. Prospective monitoring of these 17 patients in the intervention arm was collected. Retrospective data on 20 consecutive patients who underwent craniofacial surgery prior to the initiation of the program were used as a control group. The primary endpoint was the transfusion volume of blood products.
RESULTS:
Groups at baseline were similar in age, weight and reported intraoperative estimated blood loss. Patients post-intervention had a higher mean ASA classification. The rate of transfusion decreased from 80% pre-intervention to 65% post-intervention. Post-intervention, patients received a mean of 106 mL of intraoperative PRBC, while pre-intervention, patients received a mean of 224 mL. (p=0.024). Postoperative hemoglobin measurements were similar, with the control group 10.9 g/dL and the intervention arm 10.5 g/ dL (p=0.64). Discharge hemoglobin concentrations also were similar with 9.6 g/dL and 10.6 g/ dL in the control and PBM group, respectively (p=0.196). Furthermore, 3 patients were found to have von Willebrand's disease preoperatively.
CONCLUSION:
We found that the institution of a Pediatric Blood Management team significantly reduced the transfusion burden of patients undergoing craniofacial procedures, including in complex patients with von Willebrand's disease. The use of a multimodal approach to hematologic management optimized patients for their procedures and helped minimize exposure to transfusion associated complications. Craniofacial scoliosis secondary to unicoronal synostosis (UCS) has been widely observed to encompass the vault, the cranial base, and the face. While the basic differences have been recorded, a thorough analysis of the cranial base and intra-cranial craniometric, and volumetric differences have not. We hypothesized that patients with UCS have deviation of the vault, cranial base, and face resulting in significant differences in skull base morphology and segmental cranial vault volume relative to non-affected controls.
A Craniometric Analysis of Cranial Base Differences in Unicoronal Craniosynostosis
METHODS: UCS patients with high-resolution pre-operative CT scans were collected from our IRB-approved, prospective, craniofacial registry. Patients with UCS were compared to a trauma registry (without cranial pathology) and positive controls (positional plagiocephaly). Mimics® software was used to compare those with UCS to controls for a series of standardized craniometric angles and distances. A segmented volumetric
